Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Harte-Hanks Q3 2023 EPS $0.08 Misses $0.18 Estimate, Sales $47.12M Miss $47.70M Estimate

Author: Benzinga Newsdesk | November 09, 2023 05:24pm
Harte-Hanks (NASDAQ:HHS) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.18 by 55.56 percent. This is a 90.36 percent decrease over earnings of $0.83 per share from the same period last year. The company reported quarterly sales of $47.12 million which missed the analyst consensus estimate of $47.70 million by 1.22 percent. This is a 12.56 percent decrease over sales of $53.89 million the same period last year.

Posted In: HHS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist